Literature DB >> 8476252

Diabetic nephropathy: pathogenesis and treatment.

S Adler1, C Nast, A Artishevsky.   

Abstract

Diabetic nephropathy is a leading cause of end-stage renal disease. Recently, there have been developments in understanding the role of risk factors and pathogenetic features such as genetic predisposition, systemic and intraglomerular hypertension, the effects of glycemic control, glomerular hypertrophy, and basic biochemical alterations in cellular metabolism, as well as correlations in morphology and function. These are reflected in newer approaches to preventive and palliative therapy.

Entities:  

Mesh:

Year:  1993        PMID: 8476252     DOI: 10.1146/annurev.me.44.020193.001511

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  2 in total

1.  Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.

Authors:  Kirti Bhatt; Linda L Lanting; Ye Jia; Sailee Yadav; Marpadga A Reddy; Nathaniel Magilnick; Mark Boldin; Rama Natarajan
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

2.  Effects of Curcumin on High Glucose-Induced Epithelial-to-Mesenchymal Transition in Renal Tubular Epithelial Cells Through the TLR4-NF-κB Signaling Pathway.

Authors:  Xinhui Liu; Xiuli Zhang; Xiaoyi Cai; Jiqiu Dong; Yinmao Chi; Zhihong Chi; Harvest F Gu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-02       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.